Lamotrigine Extended-Release in Elderly Patients With Epilepsy
Lamotrigine Extended-Release in Elderly Patients With Epilepsy
This study is being conducted to determine the safety and tolerability of lamotrigine (LTG) in elderly patients with epilepsy. This study will be carried out using an extended-release formulation of lamotrigine (LTG-XR) that will allow once-a-day dosing.
Inclusion criteria:
Exclusion criteria:
Fullteron, California 92835, United States